NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from XTP? Mail in a sample (US only) and let us test it.

Test my supply
69%
Finnrick rating
#224 of 344 ranked vendors
6 of 10 classifiable tests passed
methodology · Purity focus
Finnrick analysis

XTP's Purity focus record is narrow but mostly strong, centered on Retatrutide with earlier high-purity identity and fill passes. The profile is less settled because a recent 92.8% purity Retatrutide result breaks the prior pattern, and several older reports lacked batch identifiers.

methodology →
vendor intelligence report
Vendor Intelligence Report: XTP

XTP’s public trail runs through a privacy-protected Lithuanian domain, an unverified Xi’an company name, and a forum handoff after a representative account was banned. The report checks the Janoshik claim, warehouse context, and identity-failure dispute without overstating customs links.

16 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.75
69%
10
2
GHK-Cu
$0.08
-
0
3
KLOW
$0.12
-
0
4
Melanotan II
$0.60
-
0
5
NAD+
$0.01
-
0
6
Tesamorelin
$1.80
-
0
7
Tirzepatide
$0.43
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%15 Jan 2026: 77%22 Jan 2026: 78%26 Jan 2026: 80%28 Apr 2026: 83%8 May 2026: 84%16 Jun 2026: 80%3 Aug 2026: 81%3 Sept 2026: 77%3 Sept 2026: 73%9 Sept 2026: 69%18 Sept 2026: current 69%77%83%69%Jan 26Sep 26
XTP test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Sep 2026
Fail
Retatrutide
lab nameView COA
3 Sep 2026
Fail
Retatrutide
lab nameView COA
3 Sep 2026
Fail
Retatrutide
lab nameView COA
3 Aug 2026
Pass
Retatrutide
lab nameView COA
16 Jun 2026
Fail
Retatrutide
lab nameView COA
8 May 2026
Pass
Retatrutide
lab nameView COA
28 Apr 2026
Pass
Retatrutide
lab nameView COA
26 Jan 2026
Pass
Retatrutide
lab nameView COA
22 Jan 2026
Pass
Retatrutide
lab nameView COA
15 Jan 2026
Pass
Retatrutide
lab nameView COA

About XTP test results from Finnrick

XTP is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 10 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible XTP peptides in this dataset are Retatrutide (10 tests), GHK-Cu (0 tests) and KLOW (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 10 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from XTP? Mail in a sample (US only) and let us test it.

Test my supply